Literature DB >> 33420270

LncRNA HOTAIR regulates glucose transporter Glut1 expression and glucose uptake in macrophages during inflammation.

Monira Obaid1, S M Nashir Udden2, Prasanna Alluri2, Subhrangsu S Mandal3.   

Abstract

Inflammation plays central roles in the immune response. Inflammatory response normally requires higher energy and therefore is associated with glucose metabolism. Our recent study demonstrates that lncRNA HOTAIR plays key roles in NF-kB activation, cytokine expression, and inflammation. Here, we investigated if HOTAIR plays any role in the regulation of glucose metabolism in immune cells during inflammation. Our results demonstrate that LPS-induced inflammation induces the expression of glucose transporter isoform 1 (Glut1) which controls the glucose uptake in macrophages. LPS-induced Glut1 expression is regulated via NF-kB activation. Importantly, siRNA-mediated knockdown of HOTAIR suppressed the LPS-induced expression of Glut1 suggesting key roles of HOTAIR in LPS-induced Glut1 expression in macrophage. HOTAIR induces NF-kB activation, which in turn increases Glut1 expression in response to LPS. We also found that HOTAIR regulates glucose uptake in macrophages during LPS-induced inflammation and its knockdown decreases LPS-induced increased glucose uptake. HOTAIR also regulates other upstream regulators of glucose metabolism such as PTEN and HIF1α, suggesting its multimodal functions in glucose metabolism. Overall, our study demonstrated that lncRNA HOTAIR plays key roles in LPS-induced Glut1 expression and glucose uptake by activating NF-kB and hence HOTAIR regulates metabolic programming in immune cells potentially to meet the energy needs during the immune response.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33420270      PMCID: PMC7794310          DOI: 10.1038/s41598-020-80291-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  106 in total

Review 1.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Damage associated molecular pattern molecules.

Authors:  Michael T Lotze; Albert Deisseroth; Anna Rubartelli
Journal:  Clin Immunol       Date:  2007-04-30       Impact factor: 3.969

Review 3.  Inflammatory pathways in female reproductive health and disease.

Authors:  Henry N Jabbour; Kurt J Sales; Rob D Catalano; Jane E Norman
Journal:  Reproduction       Date:  2009-09-30       Impact factor: 3.906

Review 4.  Nonresolving inflammation.

Authors:  Carl Nathan; Aihao Ding
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 5.  Role of perinatal inflammation in cerebral palsy.

Authors:  Sylvie Girard; Hazim Kadhim; Mélanie Roy; Karine Lavoie; Marie-Elsa Brochu; Annie Larouche; Guillaume Sébire
Journal:  Pediatr Neurol       Date:  2009-03       Impact factor: 3.372

Review 6.  Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4.

Authors:  Eva M Pålsson-McDermott; Luke A J O'Neill
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

Review 7.  LPS/TLR4 signal transduction pathway.

Authors:  Yong-Chen Lu; Wen-Chen Yeh; Pamela S Ohashi
Journal:  Cytokine       Date:  2008-03-04       Impact factor: 3.861

Review 8.  Inflammatory mechanisms: the molecular basis of inflammation and disease.

Authors:  Peter Libby
Journal:  Nutr Rev       Date:  2007-12       Impact factor: 7.110

9.  Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox.

Authors:  Anna Rubartelli; Michael T Lotze
Journal:  Trends Immunol       Date:  2007-09-12       Impact factor: 16.687

Review 10.  Inflammatory responses and inflammation-associated diseases in organs.

Authors:  Linlin Chen; Huidan Deng; Hengmin Cui; Jing Fang; Zhicai Zuo; Junliang Deng; Yinglun Li; Xun Wang; Ling Zhao
Journal:  Oncotarget       Date:  2017-12-14
View more
  8 in total

Review 1.  Myeloid cell-targeted therapies for solid tumours.

Authors:  Sangeeta Goswami; Swetha Anandhan; Deblina Raychaudhuri; Padmanee Sharma
Journal:  Nat Rev Immunol       Date:  2022-06-13       Impact factor: 53.106

2.  ImReLnc: Identifying Immune-Related LncRNA Characteristics in Human Cancers Based on Heuristic Correlation Optimization.

Authors:  Meihong Gao; Shuhui Liu; Yang Qi; Xinpeng Guo; Xuequn Shang
Journal:  Front Genet       Date:  2022-01-10       Impact factor: 4.599

Review 3.  The Role of Long Non-Coding RNAs (lncRNAs) in Female Oriented Cancers.

Authors:  Faiza Naz; Imran Tariq; Sajid Ali; Ahmed Somaida; Eduard Preis; Udo Bakowsky
Journal:  Cancers (Basel)       Date:  2021-12-03       Impact factor: 6.639

4.  Silica-coated magnetic-nanoparticle-induced cytotoxicity is reduced in microglia by glutathione and citrate identified using integrated omics.

Authors:  Tae Hwan Shin; Balachandran Manavalan; Da Yeon Lee; Shaherin Basith; Chan Seo; Man Jeong Paik; Sang-Wook Kim; Haewoon Seo; Ju Yeon Lee; Jin Young Kim; A Young Kim; Jee Min Chung; Eun Joo Baik; Seong Ho Kang; Dong-Kug Choi; Yup Kang; M Maral Mouradian; Gwang Lee
Journal:  Part Fibre Toxicol       Date:  2021-11-25       Impact factor: 9.400

Review 5.  Roles of MicroRNA-21 in Skin Wound Healing: A Comprehensive Review.

Authors:  Jie Xie; Weizhou Wu; Liying Zheng; Xuesong Lin; Yuncheng Tai; Yajie Wang; Le Wang
Journal:  Front Pharmacol       Date:  2022-02-28       Impact factor: 5.810

6.  Association of Polymorphisms within HOX Transcript Antisense RNA (HOTAIR) with Type 2 Diabetes Mellitus and Laboratory Characteristics: A Preliminary Case-Control Study.

Authors:  Saman Sargazi; Mahdiyeh Ravanbakhsh; Milad Heidari Nia; Shekoufeh Mirinejad; Roghayeh Sheervalilou; Mahdi Majidpour; Hiva Danesh; Ramin Saravani
Journal:  Dis Markers       Date:  2022-03-22       Impact factor: 3.434

7.  Non-Invasive Differentiation of M1 and M2 Activation in Macrophages Using Hyperpolarized 13C MRS of Pyruvate and DHA at 1.47 Tesla.

Authors:  Kai Qiao; Lydia M Le Page; Myriam M Chaumeil
Journal:  Metabolites       Date:  2021-06-22

Review 8.  LncRNA: A Potential Target for Host-Directed Therapy of Candida Infection.

Authors:  Ye Wang; Hongdan Xu; Na Chen; Jin Yang; Hongmei Zhou
Journal:  Pharmaceutics       Date:  2022-03-11       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.